Literature DB >> 8326441

An experimental canine model of osteonecrosis: characterization of the repair process.

K N Malizos1, L D Quarles, A V Seaber, W S Rizk, J R Urbaniak.   

Abstract

Osteonecrosis of the femoral head was induced in dogs by a process of deep freezing, accompanied by stripping of the soft-tissue attachments from the femoral neck and intertrochanteric area, in an effort to develop an experimental model to study treatment modalities for avascular necrosis of the hip. Immediate uniform necrosis was created in a defined area. Thereafter, spontaneous healing originated mainly from the adjacent viable bone by migration of undifferentiated mesenchymal tissue into the necrotic bone, genesis of fibrosis, and, finally, formation of new bone. Osteogenesis occurred primarily through intramembranous ossification without a preexisting template. Quantitative measurements showed a difference in the rates of ingrowth and revascularization of the necrotic area during the fibrotic and osteogenic phases of the healing. The de novo osteogenesis was slower than the migration of fibrosis. These findings indicate that, without osteotomy, we can reproducibly create necrosis of bone in a defined area of the proximal femur and induce a reparative process that incompletely heals the defect. Although it does not fully simulate the human disorder of osteonecrosis, our experimental surgical model provides a basis for further laboratory investigation into the management of avascular necrosis of the femoral head.

Entities:  

Mesh:

Year:  1993        PMID: 8326441     DOI: 10.1002/jor.1100110306

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  15 in total

1.  Development of a mouse model of ischemic osteonecrosis.

Authors:  Nobuhiro Kamiya; Ryosuke Yamaguchi; Olumide Aruwajoye; Naga Suresh Adapala; Harry K W Kim
Journal:  Clin Orthop Relat Res       Date:  2015-02-10       Impact factor: 4.176

2.  A new osteonecrosis animal model of the femoral head induced by microwave heating and repaired with tissue engineered bone.

Authors:  Yanlin Li; Rui Han; Chengkui Geng; Yongnian Wang; Lei Wei
Journal:  Int Orthop       Date:  2008-10-28       Impact factor: 3.075

Review 3.  Experimental animal models of osteonecrosis.

Authors:  Meng Fan; Jiang Peng; Ling Qin; Shibi Lu
Journal:  Rheumatol Int       Date:  2011-02-22       Impact factor: 2.631

4.  Blood supply to the chicken femoral head.

Authors:  Jianzhong Xu; Xiuli Wang; C Brian Toney; Jesse Seamon; Quanjun Cui
Journal:  Comp Med       Date:  2010-08       Impact factor: 0.982

5.  Osteonecrosis of the femoral head: An update in year 2012.

Authors:  Anjan P Kaushik; Anusuya Das; Quanjun Cui
Journal:  World J Orthop       Date:  2012-05-18

6.  Injury-to-surgery interval does not affect the occurrence of osteonecrosis of the femoral head: a prospective study in a canine model of femoral neck fractures.

Authors:  You-Shui Gao; Zhen-Hong Zhu; Sheng-Bao Chen; Xiang-Guo Cheng; Dong-Xu Jin; Chang-Qing Zhang
Journal:  Med Sci Monit       Date:  2012-07

7.  An animal model of femoral head osteonecrosis induced by a single injection of absolute alcohol: an experimental study.

Authors:  Zhen-Hong Zhu; You-Shui Gao; Shi-Hua Luo; Bing-Fang Zeng; Chang-Qing Zhang
Journal:  Med Sci Monit       Date:  2011-04

8.  HGF-transgenic MSCs can improve the effects of tissue self-repair in a rabbit model of traumatic osteonecrosis of the femoral head.

Authors:  Qian Wen; Dan Jin; Chao-Ying Zhou; Ming-Qian Zhou; Wei Luo; Li Ma
Journal:  PLoS One       Date:  2012-05-21       Impact factor: 3.240

Review 9.  Vasculature deprivation--induced osteonecrosis of the rat femoral head as a model for therapeutic trials.

Authors:  Jacob Bejar; Eli Peled; Jochanan H Boss
Journal:  Theor Biol Med Model       Date:  2005-07-05       Impact factor: 2.432

10.  Development of a clinically relevant animal model for the talar osteonecrosis in sheep.

Authors:  Chao-Fan Yuan; Jun-Lin Wang; Yong-Quan Zhang; Xiao-Kang Li; Yi Li; Su-Hua Wu; Zhi-Yong Zhang; Zheng Guo
Journal:  Int J Med Sci       Date:  2012-10-27       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.